210 related articles for article (PubMed ID: 2903953)
21. Temporary increase in serum beta 2-microglobulin during treatment with interferon-alpha for AIDS-associated Kaposi's sarcoma.
de Wit R; Bakker PJ; Reiss P; Hoek FJ; Lange JM; Goudsmit J; Veenhof KH
AIDS; 1990 May; 4(5):459-62. PubMed ID: 2196909
[TBL] [Abstract][Full Text] [Related]
22. Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS).
Kovacs JA; Deyton L; Davey R; Falloon J; Zunich K; Lee D; Metcalf JA; Bigley JW; Sawyer LA; Zoon KC
Ann Intern Med; 1989 Aug; 111(4):280-7. PubMed ID: 2757312
[TBL] [Abstract][Full Text] [Related]
23. Phase I/II trials of alpha-interferon alone or in combination with zidovudine as maintenance therapy following induction chemotherapy in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma.
Gill PS
Semin Oncol; 1991 Oct; 18(5 Suppl 7):53-7. PubMed ID: 1719642
[TBL] [Abstract][Full Text] [Related]
24. Interferon alpha in the treatment of AIDS-related Kaposi's sarcoma.
Mitsuyasu RT
Br J Haematol; 1991 Oct; 79 Suppl 1():69-73. PubMed ID: 1931714
[TBL] [Abstract][Full Text] [Related]
25. Low incidence of anti-interferon-alpha antibodies in patients treated with interferon-alpha-2a for AIDS-associated Kaposi's sarcoma.
de Wit R; Bakker PJ; Danner SA; Goudsmit J; Veenhof KH
Int J STD AIDS; 1990 Jul; 1(4):256-8. PubMed ID: 2088534
[TBL] [Abstract][Full Text] [Related]
26. [Interferon alpha 2C in the treatment of 2 patients with AIDS-associated Kaposi sarcoma].
Steger G; Dittrich C; Eichler HG; Flener R; Moser K
Wien Klin Wochenschr; 1987 Feb; 99(4):120-3. PubMed ID: 3577187
[TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up of non-HIV Kaposi's sarcoma treated with low-dose recombinant interferon alfa-2b.
Costa da Cunha CS; Lebbe C; Rybojad M; Agbalika F; Ferchal F; Rabian C; Vignon-Pennamen MD; Calvo F; Morel P
Arch Dermatol; 1996 Mar; 132(3):285-90. PubMed ID: 8607632
[TBL] [Abstract][Full Text] [Related]
28. Treatment of epidemic Kaposi's sarcoma with a combination of interferon-alpha 2b and etoposide.
Krigel RL; Slywotzky CM; Lonberg M; Green MD; Andes WA; Kempf R; Gupta S; Grace W; Spiegel RJ; Muggia FM
J Biol Response Mod; 1988 Aug; 7(4):359-64. PubMed ID: 3049944
[TBL] [Abstract][Full Text] [Related]
29. Reversible diabetes in patient with AIDS-related Kaposi's sarcoma treated with interferon alpha-2a.
Gori A; Caredda F; Franzetti F; Ridolfo A; Rusconi S; Moroni M
Lancet; 1995 Jun; 345(8962):1438-9. PubMed ID: 7760627
[No Abstract] [Full Text] [Related]
30. Long-term follow-up of 120 patients with AIDS-related Kaposi's sarcoma treated with interferon alpha-2a.
Rozenbaum W; Gharakhanian S; Navarette MS; De Sahb R; Cardon B; Rouzioux C
J Invest Dermatol; 1990 Dec; 95(6 Suppl):161S-165S. PubMed ID: 2124245
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of 5 patients affected by Kaposi's sarcoma and AIDS with recombinant interferon alfa-2A (roferon-A)].
Lopez Bran E; Aguilar R; Marron JA; Figueredo MA; Garcia Ruiz JM
Med Cutan Ibero Lat Am; 1989; 17(4):269-73. PubMed ID: 2693866
[TBL] [Abstract][Full Text] [Related]
32. Lymphangioma-like variant of AIDS-associated Kaposi's sarcoma with pronounced edema formation.
Bossuyt L; Van den Oord JJ; Degreef H
Dermatology; 1995; 190(4):324-6. PubMed ID: 7655117
[TBL] [Abstract][Full Text] [Related]
33. Treatment of acquired immunodeficiency syndrome--related Kaposi's sarcoma with lymphoblastoid interferon.
Rios A; Mansell PW; Newell GR; Reuben JM; Hersh EM; Gutterman JU
J Clin Oncol; 1985 Apr; 3(4):506-12. PubMed ID: 3872349
[TBL] [Abstract][Full Text] [Related]
34. Therapy of epidemic Kaposi's sarcoma.
Groopman JE
Semin Hematol; 1986 Jul; 23(3 Suppl 1):14-9. PubMed ID: 3090689
[TBL] [Abstract][Full Text] [Related]
35. Kaposi's sarcoma and the acquired immunodeficiency syndrome: treatment with high and low doses of recombinant leukocyte A interferon.
Real FX; Oettgen HF; Krown SE
J Clin Oncol; 1986 Apr; 4(4):544-51. PubMed ID: 3958767
[TBL] [Abstract][Full Text] [Related]
36. GM-CSF as an alternative to dose modification of the combination zidovudine and interferon-alpha in the treatment of AIDS-associated Kaposi's sarcoma.
Scadden DT; Bering HA; Levine JD; Bresnahan J; Evans L; Epstein C; Groopman JE
Am J Clin Oncol; 1991; 14 Suppl 1():S40-4. PubMed ID: 2048563
[TBL] [Abstract][Full Text] [Related]
37. Treatment of AIDS-associated Kaposi's sarcoma with recombinant alpha interferon.
Oettgen HF; Real FX; Krown SE
Immunobiology; 1986 Sep; 172(3-5):269-74. PubMed ID: 3804369
[No Abstract] [Full Text] [Related]
38. [Roferon-A (interferon alfa-2a) permitted for AIDS-associated Kaposi's sarcoma by the BGA].
Immun Infekt; 1989 Feb; 17(1):VIII. PubMed ID: 2925218
[No Abstract] [Full Text] [Related]
39. Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome.
Groopman JE; Gottlieb MS; Goodman J; Mitsuyasu RT; Conant MA; Prince H; Fahey JL; Derezin M; Weinstein WM; Casavante C
Ann Intern Med; 1984 May; 100(5):671-6. PubMed ID: 6712031
[TBL] [Abstract][Full Text] [Related]
40. Interferon-alpha, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I AIDS Clinical Trials Group study in patients with Kaposi's sarcoma associated with AIDS.
Krown SE; Paredes J; Bundow D; Polsky B; Gold JW; Flomenberg N
J Clin Oncol; 1992 Aug; 10(8):1344-51. PubMed ID: 1634925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
